Cargando…
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature
Lipophilic but not hydrophilic statins have been shown to be associated with reduced risk for hepatocellular carcinoma (HCC) in patients with chronic viral hepatitis. We investigated differential actions of lipophilic and hydrophilic statins and their ability to modulate a clinical prognostic liver...
Autores principales: | Kim, Myung‐Ho, Kim, Mi‐Young, Salloum, Shadi, Qian, Tongqi, Wong, Lai Ping, Xu, Min, Lee, Yoojin, Shroff, Stuti G., Sadreyev, Ruslan I., Corey, Kathleen E., Baumert, Thomas F., Hoshida, Yujin, Chung, Raymond T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426409/ https://www.ncbi.nlm.nih.gov/pubmed/35712812 http://dx.doi.org/10.1002/hep4.1991 |
Ejemplares similares
-
Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019) -
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017) -
Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018) -
Hepatitis C virus-induced hepatocellular carcinoma
por: Goossens, Nicolas, et al.
Publicado: (2015) -
MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific in Silico Prognostic Biomarker Validation
por: Yip, Shun H., et al.
Publicado: (2019)